Pretreatment with subeffective doses of Rimonabant attenuates orexigenic actions of orexin A-hypocretin 1
- 31 January 2008
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 54 (1), 219-225
- https://doi.org/10.1016/j.neuropharm.2007.05.027
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Orexin-1 Receptor-Cannabinoid CB1 Receptor Heterodimerization Results in Both Ligand-dependent and -independent Coordinated Alterations of Receptor Localization and FunctionJournal of Biological Chemistry, 2006
- Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole – LH 21Neuropharmacology, 2006
- A role for lateral hypothalamic orexin neurons in reward seekingNature, 2005
- Long-Lasting Increase of Alcohol Relapse by the Cannabinoid Receptor Agonist WIN 55,212-2 during Alcohol DeprivationJournal of Neuroscience, 2004
- The molecular logic of endocannabinoid signallingNature Reviews Neuroscience, 2003
- Introduction The Neurobiology of Cannabinoid Transmission: From Anandamide Signaling to Higher Cerebral Functions and DiseaseNeurobiology of Disease, 1998
- Hyperphagia in pre-fed rats following oral δ9-THCPhysiology & Behavior, 1998
- Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the ratNeuroReport, 1997
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorFEBS Letters, 1994
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992